Glaxosmithkline Consumer Healthcare Holdings recalls Advil Liqui-Gel Mini 160+20+20 CT (e-commerce) NDC # 0573-1715-59 SKU# F00573171559 (original lot # R53074) Co-packaged…
- Recall date
- March 16, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1069-2020
- FDA classification
- Class II
- Brand / firm
- Glaxosmithkline Consumer Healthcare Holdings
- Sold / distributed
- Product was distributed throughout the United States, including Puerto Rico.
Why it was recalled
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Advil Liqui-Gel Mini 160+20+20 CT (e-commerce) NDC # 0573-1715-59 SKU# F00573171559 (original lot # R53074) Co-packaged Batch/Lot # 0198FR & 3188FRB
Get recall alerts
Free email alert whenever Glaxosmithkline Consumer Healthcare Holdings has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Glaxosmithkline Consumer Healthcare Holdings